[{"command":"settings","settings":{"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJxdzTESgzAMRNELGXwkj5A3oIxAHskw5PahSOOUb3-xrHIIk5buQpp5YBqZV7XlQfSPIhKbI1c_G-lcn2zrTG-6h73TonBEsyPkQqq2_9IUIOct1bt56Rt2_IUz4FGa20sU4_UXMsFHBg","theme":"dom","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true},"user":{"uid":0,"permissionsHash":"f19a384da5e49731bd85978886b67fbeb85b0343b7abae302ec5f3b07d632542"}},"merge":true},{"command":"add_css","data":[{"rel":"stylesheet","media":"all","href":"\/sites\/default\/files\/css\/css_xcpT9Fvgn2wp-GtR48noIQiwcegZEryeOQfBd_mVJX0.css?delta=0\u0026language=en\u0026theme=dom\u0026include=eJxVyUEOgDAIAMEPVfukBoG0JFQaion-3h68eNwdVDkFQUu4gOaqdqyY8SjPhOacya8ButNiq4msf2ebDI4t0T28ROPOf3gBQswjBA"},{"rel":"stylesheet","media":"all","href":"\/sites\/default\/files\/css\/css_TJEE9ih8yXWiwXfh1XkX5VjD1unNxWNTIHWJFfX7lgw.css?delta=1\u0026language=en\u0026theme=dom\u0026include=eJxVyUEOgDAIAMEPVfukBoG0JFQaion-3h68eNwdVDkFQUu4gOaqdqyY8SjPhOacya8ButNiq4msf2ebDI4t0T28ROPOf3gBQswjBA"}]},{"command":"add_js","selector":"body","data":[{"src":"\/sites\/default\/files\/js\/js_ZG-UHngUBZs7jI1Jt5KBM3KRisDcwhTB9jhRdwthOiE.js?scope=footer\u0026delta=0\u0026language=en\u0026theme=dom\u0026include=eJxVjFEKwCAMxS4keiTptJOOh5VWx3b7-bvPJJAC6VIIeZoQUoMeG3y-YA9FjVO1NQix7qwt0kXPz086wMY-tLvcHJazeR6mp4D_vw8HWyq7"}]},{"command":"insert","method":"html","selector":".result_message","data":"","settings":null},{"command":"insert","method":"append","selector":".result_message","data":"\u003Cdiv class=\u0022result_message\u0022\u003E\u003Cform class=\u0022dn-student-table-form\u0022 data-drupal-selector=\u0022dn-student-table-form\u0022 action=\u0022\/ajax\/clinical_trial\/table\/page\/3\u0022 method=\u0022post\u0022 id=\u0022dn-student-table-form\u0022 accept-charset=\u0022UTF-8\u0022\u003E\n  \u003Cdiv class=\u0022table-responsive\u0022\u003E\n\u003Ctable class=\u0022table table-bordered rounded overflow-hidden search-result responsive-enabled\u0022 data-drupal-selector=\u0022edit-table\u0022 id=\u0022edit-table\u0022 data-striping=\u00221\u0022\u003E\n  \n  \n  \n      \u003Cthead\u003E\n      \u003Ctr\u003E\n                            \u003Cth\u003ETitle\u003C\/th\u003E\n                            \u003Cth\u003EDisease Or Condition\u003C\/th\u003E\n                            \u003Cth\u003EInvestigator(s)\u003C\/th\u003E\n                            \u003Cth\u003EDivision\u003C\/th\u003E\n                            \u003Cth\u003ETherapies\u003C\/th\u003E\n                            \u003Cth\u003EStudy Status\u003C\/th\u003E\n              \u003C\/tr\u003E\n    \u003C\/thead\u003E\n  \n      \u003Ctbody\u003E\n                      \u003Ctr class=\u0022odd\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT07189936\u0022 target=\u0022_blank\u0022 title=\u0022Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS\u0022\u003EEffect of 2-HOBA in Persistent Immune Activation in Long COVID POTS\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EPost-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), SARS CoV 2 Infection, Long COVID19\u003C\/td\u003E\n                      \u003Ctd\u003ECyndya Shibao, MD\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022even\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT04502225\u0022 target=\u0022_blank\u0022 title=\u0022Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure\u0022\u003EEffect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003ESupine Hypertension, Autonomic Failure\u003C\/td\u003E\n                      \u003Ctd\u003EItalo Biaggioni\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022odd\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT07602166\u0022 target=\u0022_blank\u0022 title=\u0022Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans\u0022\u003EEffect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003ESalt Sensitivity of Blood Pressure, High Blood Pressure, Inflammation, Renin-Angiotensin-Aldosterone System\u003C\/td\u003E\n                      \u003Ctd\u003EAnnet Kirabo\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ENot Yet Recruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022even\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT02897063\u0022 target=\u0022_blank\u0022 title=\u0022Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure\u0022\u003EEffects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EAutonomic Failure, Pure Autonomic Failure, Multiple System Atrophy, Parkinson Disease, Orthostatic Hypotension\u003C\/td\u003E\n                      \u003Ctd\u003EItalo Biaggioni\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022odd\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT06573411\u0022 target=\u0022_blank\u0022 title=\u0022Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy\u0022\u003EEfficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EPrimary Membranous Nephropathy\u003C\/td\u003E\n                      \u003Ctd\u003EWei Chen\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022even\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT06399640\u0022 target=\u0022_blank\u0022 title=\u0022Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia\u0022\u003EEltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003ERelapsed Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia\u003C\/td\u003E\n                      \u003Ctd\u003ESomedeb Ball\u003C\/td\u003E\n                      \u003Ctd\u003EHO\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022odd\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT04769206\u0022 target=\u0022_blank\u0022 title=\u0022Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans\u0022\u003EEnhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EEndothelial Dysfunction\u003C\/td\u003E\n                      \u003Ctd\u003ECyndya Shibao, MD\u003C\/td\u003E\n                      \u003Ctd\u003EGE\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022even\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT07221214\u0022 target=\u0022_blank\u0022 title=\u0022GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV\u0022\u003EGLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EHIV, Alcohol, Smoking Cigarette, Cardiovascular Disease Prevention\u003C\/td\u003E\n                      \u003Ctd\u003EHilary Tindle\u003C\/td\u003E\n                      \u003Ctd\u003EIM\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022odd\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT05693766\u0022 target=\u0022_blank\u0022 title=\u0022Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort\u0022\u003EGene Signatures to Guide HR+MBC Therapy in a Diverse Cohort\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EInvasive Mammary Carcinoma, Metastatic Breast Cancer\u003C\/td\u003E\n                      \u003Ctd\u003ESonya Reid\u003C\/td\u003E\n                      \u003Ctd\u003EHO\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n                      \u003Ctr class=\u0022even\u0022\u003E\n                      \u003Ctd\u003E\u003Ca style=\u0022text-decoration: none;\u0022href=\u0022https:\/\/www.clinicaltrials.gov\/study\/NCT05361720\u0022 target=\u0022_blank\u0022 title=\u0022Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study\u0022\u003EGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study\u003C\/a\u003E\u003C\/td\u003E\n                      \u003Ctd\u003EAdvanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8\u003C\/td\u003E\n                      \u003Ctd\u003EBrian Rini\u003C\/td\u003E\n                      \u003Ctd\u003EHO\u003C\/td\u003E\n                      \u003Ctd\u003EINTERVENTIONAL\u003C\/td\u003E\n                      \u003Ctd\u003ERecruiting\u003C\/td\u003E\n                  \u003C\/tr\u003E\n          \u003C\/tbody\u003E\n    \u003C\/table\u003E\n\u003C\/div\u003E\u003Cdiv class=\u0022pagination\u0022\u003E\u003Cul class=\u0022pagination\u0022\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/0\u0022 class=\u0022use-ajax showPage\u0022\u003EFirst\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/1\u0022 class=\u0022use-ajax pagination-link showPage\u0022\u003E1\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/2\u0022 class=\u0022use-ajax pagination-link showPage\u0022\u003E2\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/3\u0022 class=\u0022use-ajax pagination-link showPage active\u0022\u003E3\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/4\u0022 class=\u0022use-ajax pagination-link showPage\u0022\u003E4\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/5\u0022 class=\u0022use-ajax pagination-link showPage\u0022\u003E5\u003C\/a\u003E\u003Ca href=\u0022\/ajax\/clinical_trial\/table\/page\/5\u0022 class=\u0022use-ajax showPage\u0022\u003ELast\u003C\/a\u003E\u003C\/ul\u003E\u003C\/div\u003E\n  \u003Cinput autocomplete=\u0022off\u0022 data-drupal-selector=\u0022form-bvjaafy2qxqzpxuhgkke2wpgwmpfldyiire9m42vaiq\u0022 type=\u0022hidden\u0022 name=\u0022form_build_id\u0022 value=\u0022form-bvJaAFY2QxqZpxuhgKKe2WPgWmpfldYiiRE9m42VaiQ\u0022 \/\u003E\n\n\n  \u003Cinput data-drupal-selector=\u0022edit-dn-student-table-form\u0022 type=\u0022hidden\u0022 name=\u0022form_id\u0022 value=\u0022dn_student_table_form\u0022 \/\u003E\n\n\n\u003C\/form\u003E\n","settings":null}]